Medi Assist Healthcare Services Limited has informed the Exchange regarding Outcome of Board Meeting held on August 07, 2025.
MEDIASSIST · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.5 pts less than its Insurance peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Medi Assist reported Q1 FY26 consolidated revenue from operations of Rs. 1,905.58 million, up about 13.6% from Rs. 1,677.06 million in Q1 FY25, while net profit rose roughly 19.5% to Rs. 226.31 million from Rs. 189.45 million. On a standalone basis, revenue grew sharply by about 27.7% to Rs. 437.04 million, though standalone profit dipped slightly to Rs. 80.20 million from Rs. 86.74 million. The Board approved raising up to Rs. 198 crore via preferential allotment of 37 lakh equity shares at Rs. 535 each to MIT and 238 Plan Associates LLC, both qualified institutional buyers. The company also completed the Rs. 311.8 crore acquisition of Paramount Healthcare TPA on July 1, 2025, and nominated an independent director to its board. The auditors flagged an Emphasis of Matter regarding an Enforcement Directorate search and seizure at the Ranchi office of wholly owned subsidiary MAITPA, which is involved in the Ayushman Bharat health scheme; management sees no adverse financial impact.
The fundraise from a prestigious global investor like MIT signals confidence in the business, but it will dilute existing shareholders by roughly 10%. The completed Paramount acquisition boosts scale in the TPA business, while the ED investigation at the Jharkhand subsidiary remains an unresolved overhang that investors should monitor closely.